Tag: Drug

Blockbuster weight-loss drug Wegovy is losing market share in the U.S. Here’s why

Eli Lilly is making it cheaper and easier to buy high-doses of blockbuster weight loss drug Zepbound

This new AI tool at the Food and Drug Administration promises to speed up scientific reviews

Hims & Hers stock price soars after partnership with Novo Nordisk to offer weight-loss drug Wegovy

2025 drug price rise: Pharma companies plan to make more than 250 medicines more expensive

Medicare’s new $2,000 drug cap promises hefty savings

Cassava Sciences update: SAVA stock price collapses after much-criticized Alzheimer’s drug flops

Why Ozempic, Zepbound, and other weight-loss drug dupes carry risks

WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy

Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over

FTC goes after drug middlemen for allegedly jacking up insulin prices

Novo Nordisk shares take a hit after a report revealed Eli Lilly’s better weight loss drug

FDA approves a second Alzheimer’s drug shown to delay cognitive decline

Psychedelic drug MDMA could be ‘a new avenue of treatment’ as FDA begins its first-ever review

Forget Ozempic: There could be an even more effective weight-loss drug on the way

Marijuana could share the same status as steroids, in a historic shift in U.S. drug policy

Weight-loss drug startup Metsera wants to take on Novo and Lilly. Here’s what you need to know

Eli Lilly’s weight-loss drug Zepbound might help cure your sleep apnea

Wegovy is no longer just a weight-loss drug

Frankly, CVS’s simplified drug pricing plan is more confusing than ever

Why is Novo Nordisk’s stock up? Here’s what to know about its weight-loss drug Wegovy’s heart disease trials

Now Ozempic could cure drug addiction as well as obesity

FTC asks court to hold Martin Shkreli in contempt for launching new drug company

The first CRISPR gene-editing drug is coming—possibly as soon as next year

Pfizer Pumps $200M Into CStone for Rights to PD-L1 Cancer Drug in China

Bristol Myers to Buy MyoKardia, FDA-Ready Heart Disease Drug for $13.1B

In RNAi Move, Takeda Fronts $300M to Team Up on Arrowhead Liver Drug

FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats

“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug

Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma

Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects

Animal feed suppliers are running out of a horse deworming drug because people want it for COVID

Pfizer Pumps $200M Into CStone for Rights to PD-L1 Cancer Drug in China

Bristol Myers to Buy MyoKardia, FDA-Ready Heart Disease Drug for $13.1B

In RNAi Move, Takeda Fronts $300M to Team Up on Arrowhead Liver Drug

FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats

“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug

Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma

Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects

The COVID-19 drug remdesivir costs as much as $3,120 per patient, but the government could change that

This seaweed extract outperforms COVID-19 drug remdesivir in the lab

Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact